World Journal of Clinical Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 1637600

Number of visits today: 368

Number of downloads: 771105

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNALS

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Issue 9 (102)

Contents Volume 13 Issue 9 September 24, 2022

Minireviews

Hyperprogression under treatment with immune-checkpoint inhibitors in patients with gastrointestinal cancer: A natural process of advanced tumor progression?

Mo-Xuan Wang, Shu-Yue Gao, Fan Yang, Run-Jia Fan, Qin-Na Yang, Tian-Lan Zhang, Nian-Song Qian, Guang-Hai Dai

World J Clin Oncol 13(9):729-737. Published online Sep 24, 2022. doi: 10.5306/wjco.v13.i9.729

Abstract (274) | Core Tip (242) | Full Article (HTML) (1299) | Tables (1-1) (119) | Full Article (PDF)-721K (129) | Audio-243K (2) | Peer-Review Report-278K (28) | Answering Reviewers-248K (29) | Received: 03/28/2022 | Revised: 06/26/2022 | Accepted: 09/12/2022 | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (0) | Total Visits (3336) | Similar Articles (0) | Timeline of Article Publication (4) | Authors Evaluation (1) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Retrospective Study

Whipple’s pancreaticoduodenectomy at a resource-poor, low-volume center in Trinidad and Tobago

Shamir O Cawich, Dexter A Thomas, Neil W Pearce, Vijay Naraynsingh

World J Clin Oncol 13(9):738-747. Published online Sep 24, 2022. doi: 10.5306/wjco.v13.i9.738

Abstract (286) | Core Tip (264) | Article Highlights (271) | Full Article (HTML) (1138) | Figures (1-2) (94) | Tables (1-5) (109) | Full Article (PDF)-796K (150) | Audio-535K (1) | Peer-Review Report-197K (47) | Answering Reviewers-136K (47) | Received: 05/18/2022 | Revised: 07/22/2022 | Accepted: 08/17/2022 | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (1) | Total Visits (4670) | Similar Articles (65) | Timeline of Article Publication (1) | Authors Evaluation (1) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Observational Study

Factors predicting upstaging from clinical N0 to pN2a/N3a in breast cancer patients

Goshi Oda, Tsuyoshi Nakagawa, Hiroki Mori, Iichiro Onishi, Tomoyuki Fujioka, Mio Mori, Kazunori Kubota, Ryoichi Hanazawa, Akihiro Hirakawa, Toshiaki Ishikawa, Kentaro Okamoto, Hiroyuki Uetakesszsz

World J Clin Oncol 13(9):748-757. Published online Sep 24, 2022. doi: 10.5306/wjco.v13.i9.748

Abstract (267) | Core Tip (245) | Article Highlights (233) | Full Article (HTML) (1037) | Figures (1-3) (115) | Tables (1-3) (127) | Full Article (PDF)-917K (115) | Audio-2774K (2) | Peer-Review Report-794K (31) | Answering Reviewers-226K (32) | Received: 05/25/2022 | Revised: 07/25/2022 | Accepted: 09/06/2022 | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (0) | Total Visits (3971) | Similar Articles (164) | Timeline of Article Publication (2) | Authors Evaluation (1) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Letter to the Editor

Neoadjuvant immunotherapy in non-small-cell lung cancer: Times are changing—and fast

Carlos Aguado, Unai Jiménez Maestre, Xabier Mielgo-Rubio

World J Clin Oncol 13(9):758-761. Published online Sep 24, 2022. doi: 10.5306/wjco.v13.i9.758

Abstract (303) | Core Tip (214) | Full Article (HTML) (1213) | Tables (1-2) (133) | Full Article (PDF)-639K (146) | Audio-1159K (1) | Peer-Review Report-357K (28) | Answering Reviewers-143K (29) | Received: 05/09/2022 | Revised: 07/06/2022 | Accepted: 08/31/2022 | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (0) | Total Visits (3680) | Similar Articles (111) | Timeline of Article Publication (1) | Authors Evaluation (1) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Write to the Help Desk

© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345